Close Menu

Michael Eisen has a post at his It Is Not Junk blog taking on a paper from James Evans that suggests that free access to literature has little effect on citations. "This paper ... has many flaws," Eisen writes, proceeding with his list of "the most egregious." For one thing, Eisen says, citation rates aren't the best measure of the value of free access -- and for another, he notes, the raw data haven't been made available for other scientists to perform their own analyses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.